Transdermal nitroglycerin as a step 3 antihypertensive drug

Area of Science:

• Cardiology
• Pharmacology

Background:

• Hypertension remains a significant cardiovascular risk factor.
• Effective antihypertensive therapies are crucial for patient outcomes.
• Transdermal drug delivery offers potential advantages in medication management.

Purpose of the Study:

• To evaluate the antihypertensive efficacy of transdermal nitroglycerin.
• To assess the effect of transdermal nitroglycerin in patients with resistant hypertension.
• To investigate its impact on systolic and diastolic blood pressure, and heart rate.

Main Methods:

• A double-blind, randomized crossover trial was conducted.
• Eleven male patients with hypertension (diastolic blood pressure >90 mm Hg) participated.
• Subjects received escalating doses of transdermal nitroglycerin or placebo over 4-week periods.

Main Results:

• Transdermal nitroglycerin significantly reduced sitting and standing systolic blood pressure (P < 0.05).
• A mean systolic blood pressure reduction of 24 mm Hg was observed in patients with systolic hypertension (P < 0.01).
• No significant changes in diastolic blood pressure or heart rate were noted.

Conclusions:

• Transdermal nitroglycerin demonstrates a potential antihypertensive effect, particularly on systolic blood pressure.
• Its efficacy in managing systolic hypertension warrants further investigation.
• The drug may offer a therapeutic option for specific hypertensive patient groups.